InsidersTradesSigma
Browse the complete record of transactions filed by Oki Mark K, Chief Financial Officer. Director active across 1 companies, notably Aytu Biopharma, INC. Aggregated, 2 filings have been published. The latest transaction was filed on 17 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Oki Mark K is the Chief Financial Officer of AYTU BIOPHARMA, INC. He is responsible for the financial management of the company, including budgeting, financial analysis, and investment management. His expertise is essential in ensuring the financial viability and growth of the company in the biopharmaceutical sector. He plays a key role in financial strategy and decision-making.